{
    "organizations": [],
    "uuid": "d4bfcb0630df9aea94d52c724120ae36c12b8393",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-biomed-lublin-signs-cooperation-ag/brief-biomed-lublin-signs-cooperation-agreement-with-bioton-idUSFWN1Q21AR",
    "ord_in_thread": 0,
    "title": "BRIEF-Biomed Lublin Signs Cooperation Agreement With Bioton",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 12 (Reuters) - BIOMED LUBLIN:\n* SIGNS COOPERATION AGREEMENT WITH BIOTON SA ON MARKETING COâ€˜S PRODUCT DISTREPTAZA\n* UNDER DEAL CO TO SELL DISTREPTAZA EXCLUSIVELY TO BIOTON, DEAL WILL LAST TILL END OF 2022\n* CO TO PAY BIOTON REMUNERATION FOR ITS SERVICES OF PRODUCT PROMOTION DEPENDING ON VOLUMES SOLD Source text for Eikon: Further companies coverage:, (Gdynia Newsroom)\n ",
    "published": "2018-02-13T00:26:00.000+02:00",
    "crawled": "2018-02-13T16:02:23.002+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "biomed",
        "lublin",
        "sign",
        "cooperation",
        "agreement",
        "bioton",
        "sa",
        "marketing",
        "co",
        "product",
        "distreptaza",
        "deal",
        "co",
        "sell",
        "distreptaza",
        "exclusively",
        "bioton",
        "deal",
        "last",
        "till",
        "end",
        "co",
        "pay",
        "bioton",
        "remuneration",
        "service",
        "product",
        "promotion",
        "depending",
        "volume",
        "sold",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}